| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10885997 | Drug Discovery Today | 2015 | 12 Pages |
Abstract
- A steady rate of approvals for psychiatric conditions has prevailed since the 1950s.
- The indications targeted vary over time with depression dominating current approvals.
- A subset of pathways, target types and means of prosecution dominates the field.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Michael S. Kinch, Eric Patridge,